Literature DB >> 945233

The mode of action of clofazimine DNA binding studies.

N E Morrison, G M Marley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 945233

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN： 0148-916X


× No keyword cloud information.
  9 in total

Review 1.  Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis.

Authors:  Vadim Makarov; Elena Salina; Robert C Reynolds; Phyo Phyo Kyaw Zin; Sean Ekins
Journal:  J Med Chem       Date:  2020-04-20       Impact factor: 7.446

2.  A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages.

Authors:  Rahul K Keswani; Gi S Yoon; Sudha Sud; Kathleen A Stringer; Gus R Rosania
Journal:  Cytometry A       Date:  2015-06-24       Impact factor: 4.355

Review 3.  Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.

Authors:  W M Meyers; A M Marty
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters.

Authors:  Shuofeng Yuan; Xin Yin; XiangZhi Meng; Jasper Chan; Zi-Wei Ye; Laura Riva; Lars Pache; Chris Chun-Yiu Chan; Pok-Man Lai; Chris Chan; Vincent Poon; Naoko Matsunaga; Yuan Pu; Chun-Kit Yuen; Jianli Cao; Ronghui Liang; Kaiming Tang; Li Sheng; Yushen Du; Wan Xu; Kong-Hung Sze; Jinxia Zhang; Hin Chu; Kin-Hang Kok; Kelvin To; Dong-Yan Jin; Ren Sun; Sumit Chanda; Kwok-Yung Yuen
Journal:  Res Sq       Date:  2020-10-07

5.  Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids.

Authors:  C E Van Rensburg; G K Jooné; J F O'Sullivan; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

6.  Clofazimine Enteropathy: A Rare and Underrecognized Complication of Mycobacterial Therapy.

Authors:  Winnie Szeto; Monica T Garcia-Buitrago; Lilian Abbo; Joseph D Rosenblatt; Baharak Moshiree; Michele I Morris
Journal:  Open Forum Infect Dis       Date:  2016-09-02       Impact factor: 3.835

7.  Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.

Authors:  Patrick Nachipo; David Hermann; Gerald Quinnan; Melita A Gordon; Wesley C Van Voorhis; Pui-Ying Iroh Tam
Journal:  Trials       Date:  2018-08-23       Impact factor: 2.279

8.  Isolation of Burkholderia sp. HQB-1, A Promising Biocontrol Bacteria to Protect Banana Against Fusarium Wilt Through Phenazine-1-Carboxylic Acid Secretion.

Authors:  Zhizhou Xu; Mingyuan Wang; Jinpeng Du; Ting Huang; Jianfu Liu; Tao Dong; Yinglong Chen
Journal:  Front Microbiol       Date:  2020-12-10       Impact factor: 5.640

9.  Polymorphisms in the CYP2E1 and GSTM1 genes as possible protection factors for leprosy patients.

Authors:  Pablo Pinto; Claudio Guedes Salgado; Ney Santos; Dayse O Alencar; Sidney Santos; Mara H Hutz; Ândrea Ribeiro-dos-Santos
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.